The Journal of clinical endocrinology and metabolism
The most recent articles from:
August 2019
-
J. Clin. Endocrinol. Metab. · Aug 2019
Multicenter StudySGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission.
Diabetic ketoacidosis (DKA) has been associated with the use of sodium glucose cotransporter 2 inhibitors (SGLT2is). ⋯ SGLT2i users were more likely to develop DKA as an inpatient compared with non-SGLT2i users. SGLT2i use was associated with a small but significant increased risk of DKA.